Aerogen

Aerogen is the world leader in acute care aerosol drug delivery. With over 25 years of experience, 300 international patents and associated with over 200 clinical papers and publications, Aerogen technology has been used to treat 16 million patients in 75 countries worldwide. Based on pioneering vibrating mesh technology, the Aerogen Solo vibrating mesh nebulizer has become the gold standard for respiratory patient care across the hospital from the emergency department to intensive care.

The company continues to leverage its expertise, research, technologies and partnerships to make the greatest possible difference to patient outcomes.